Sells portable brain-imaging scanners to hospitals, neurology practices and other healthcare providers.
10-K for FY2025, filed Mar 18, 2026We are an innovative health technology business with a mission to revolutionize patient care globally through accessible, affordable…View ↗
Our initial commercial focus has been in the U.S. market and with customers that use the Swoop® system inside the hospital setting…View ↗
In 2025, in connection with the introduction of our next-generation Swoop® scanner and Optive AI™ software, we expanded our commercial…View ↗
Customers buy the Swoop system, usually with software, service and support. Device sales are counted when it ships; customers may pay upfront for the device and annually for service, or make annual payments over the agreement.
10-K for FY2025, filed Mar 18, 2026
10-K for FY2025, filed Mar 18, 2026
FY2025 revenue by product or service ↗$13.6M
10-K for FY2025, filed Mar 18, 2026
$13.6M ↗| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Device
Sold outright
10-K for FY2025, filed Mar 18, 2026 |
84%
FY2022: 77%
|
Device, FY2025
$11.4M Sources
|
Sold outright |
|
Service
Recurring
10-K for FY2025, filed Mar 18, 2026 |
16%
FY2022: 23%
|
Service, FY2025
$2.2M Sources
|
Recurring |
Hospitals and neurology practices in the United States buy directly; healthcare providers in other countries are served through distributors.
10-K for FY2025, filed Mar 18, 2026In 2025, in connection with the introduction of our next-generation Swoop® scanner and Optive AI™ software, we expanded our commercial…View ↗
U.S. office‑based neurology practices; andView ↗
We have built our direct commercial infrastructure in the United States and have third-party distributors responsible for commercialization…View ↗
The Swoop® system is commercially available in the United States, Canada, United Kingdom, certain European and Middle Eastern markets…View ↗
No. It lost $35.6M in FY2025.
10-K for FY2025, filed Mar 18, 2026
−$37.1MView ↗
10-K for FY2025, filed Mar 18, 2026
−$35.6MView ↗
10-K for FY2025, filed Mar 18, 2026
−$29.1MView ↗
10-Q for Q2 FY2026, filed Aug 6, 2026
−$9.3MView ↗
10-Q for Q2 FY2026, filed Aug 6, 2026
Open tableView ↗
8-K, filed Aug 6, 2026
Management continues to expect revenue for the full year 2026 to be approximately $20 to $22 million, representing 55% growth at the…View ↗
Growing. Revenue grew 9.1x in 4 years, from $1.5M in FY2021 to $13.6M in FY2025, about 74% a year.
Broader customer settings
The older report centered its commercial focus on intensive care units and emergency departments; the latest describes a broader target that includes hospital departments and office-based neurology practices.
10-K for FY2022, filed Mar 22, 2023 10-K for FY2025, filed Mar 18, 2026We believe the Swoop® system can expand the existing $28 billion global imaging market (expected to grow at a 4.9% CAGR from 2022 to 2030)…View ↗
In 2025, in connection with the introduction of our next-generation Swoop® scanner and Optive AI™ software, we expanded our commercial…View ↗
U.S. hospitals, with a focus on critical care units, emergency departments, and hospital‑based clinics;View ↗
U.S. office‑based neurology practices; andView ↗
Loading...